PHT Announces CRF Settlement, Thus Concluding Patent Infringement Lawsuits; PHT grants CRF a fully paid up worldwide license, thereby ending current litigation.CHARLESTOWN, Mass. -- PHT PHT Phenytoin (antiepileptic, Dilantin) PHT Pulmonary Hypertension PhT Pharmacy Technician PHT Post-Harvest Technology PHT Pattern History Table PHT Pressure Half Time PHT Public Health Trust Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in over 195 clinical trials worldwide, today announced that PHT and CRF CRF abbr. chronic renal failure CRF Chronic renal failure have reached a settlement in PHT's patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. lawsuit filed on January 28, 2004. Terms of the settlement remain confidential, but include a fully paid-up worldwide license for CRF Inc. and dismissal of all claims and counterclaims in the suit. "As an early innovator in ePRO solutions, we initiated the patent infringement lawsuits to protect our intellectual property," said Phil Lee, PHT President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We first settled with eTrials Worldwide, Inc. (Nasdaq: ETWC ETWC Educating the Whole Child , ETWCW, ETWCU) on August 23, 2005, and today announced settlements with the remaining two defendants, invivodata and CRF. We are pleased to settle amicably with the three defendants, thereby concluding all outstanding litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . These settlements pave the way for the customers of the three companies to take full advantage of PHT's patents, thereby increasing market adoption and driving rapid growth in the ePRO industry." About PHT Corporation PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in over 195 clinical trials worldwide. Subjects of all ages use PHT's LogPad(R) and StudyPad(R) Systems, in over 65 languages and 60 countries around the world, to enter and transmit nearly 10,000 electronic reports every day. This high quality timestamped data is used by over 70 biopharmaceutical and medical device companies to measure the safety and efficacy of new treatments for disease in many therapeutic areas, including pain, asthma, allergy, gastrointestinal distress, and disorders of the CNS See Continuous net settlement. CNS See continuous net settlement (CNS). . The data is available for real-time online use by sites and sponsors to manage research trials through PHT StudyWorks(TM), to increase subject compliance, to track enrollment and to monitor the progress of a trial. PHT, the industry leader in both experience and innovation, was the first ePRO provider to implement a study in Japan, first to incorporate Indic languages on an eDiary, and first to wirelessly integrate measurement devices with eDiaries. Subject experiences, captured firsthand by PHT's user-friendly ePRO systems, have been successfully used in at least six NDA (Non Disclosure Agreement) An agreement signed between two parties that have to disclose confidential information to each other in order to do business. In general, the NDA states why the information is being divulged and stipulates that it cannot be used for any submissions, with three known approvals to date. To find out why leading biopharmaceutical companies worldwide rely on PHT's ePRO solutions to improve data quality, reduce data variance and enhance trial management efficiencies, visit www.phtcorp.com. LogPad, StudyPad and PHT are registered trademarks of PHT Corporation. StudyWorks is a trademark of PHT Corporation. (C) 2006 PHT Corporation |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion